KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Crescent Capital BDC (CCAP) EBT (2021 - 2026)

Crescent Capital BDC filings provide 5 years of EBT readings, the most recent being $17.0 million for Q4 2025.

  • On a quarterly basis, EBT fell 17.47% to $17.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.6 million, a 24.27% decrease, with the full-year FY2025 number at $68.6 million, down 24.27% from a year prior.
  • EBT hit $17.0 million in Q4 2025 for Crescent Capital BDC, down from $17.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $24.2 million in Q3 2024 to a low of $12.3 million in Q1 2022.
  • Median EBT over the past 5 years was $17.2 million (2025), compared with a mean of $18.3 million.
  • Biggest five-year swings in EBT: skyrocketed 43.95% in 2023 and later dropped 28.87% in 2025.
  • Crescent Capital BDC's EBT stood at $13.3 million in 2021, then rose by 21.47% to $16.2 million in 2022, then skyrocketed by 43.05% to $23.2 million in 2023, then fell by 11.2% to $20.6 million in 2024, then fell by 17.47% to $17.0 million in 2025.
  • The last three reported values for EBT were $17.0 million (Q4 2025), $17.2 million (Q3 2025), and $17.3 million (Q2 2025) per Business Quant data.